SCHEMBL7001362

SCHEMBL7001362

CCn1c(=O)c2c(nc(C3CCCC3)n2Cc2ccccc2)n2nc(CO)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
PDE5A O76074 5/20 0.46
ADORA3 P0DMS8 6/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADORA2A P29274 3/20 0.40
ADORA1 P30542 2/20 0.40
MEN1 O00255 1/20 0.40
ADORA2B P29275 2/20 0.39
MAPK1 P28482 2/20 0.38
TP53 P04637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 1/20 0.38
BLM P54132 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
MAPT P10636 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6999063 0.91 KMT2A (0.48) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL7003070 0.91 PDE5A (0.48) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL6996654 0.89 KMT2A (0.46) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL6996208 0.89 PDE5A (0.47) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL7003426 0.88 KMT2A (0.46) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL7003453 0.88 PDE5A (0.45) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL7006028 0.88 KMT2A (0.45) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL7005525 0.85 KMT2A (0.48) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL7668666 0.83 POLB (0.47) KMT2APDE5AADORA3NPC1RAB9A
SCHEMBL8560623 0.83 KMT2A (0.41) KMT2APDE5AADORA3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087973-B1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA (DE) 2003-01-08 EP disclosed
US-6492377-B1 Imidazotriazolopyrimidines with adenosine-antagonistic activity BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-12-10 US disclosed
EP-1087973-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY Boehringer Ingelheim Pharma KG (DE) 2001-04-04 EP disclosed
WO-2000012511-A1 IMIDAZOTRIAZOLOPYRIMIDINES BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-03-09 WO disclosed
WO-1999065912-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-23 WO disclosed